dan barouch from boston, peter hotez in harvard -- and peter hotez from baylor, with us from houston. thank you both for sharing your expertise with our viewers. much appreciate it. have a safe memorial day weekend. >>> joining me now is the republican governor of ohio, mike dewine. governor, welcome back to "meet the press." >> good morning, chuck. >> i want to start with -- look, this memorial day weekend, one of the top places to go normally in your state would be cedar point. cedar point, an amusement park, not yet open. when do you think that's going to happen? and is that to you the real start that, okay, you're at a next level of reopening in the state of ohio? >> well, that would be a next level of reopening. chuck, i have no idea when cedar point will be able to open. our kids and grandkids love to go there. we would love to go there, but we're certainly not there yet. you know, if you look at our data, our replication rate is 1-1. we are now reopening. we've got to see how this reopening is going. reports i get back is it's going well. our restaurants are doing what they nee

peter hotez. what did you think about what you heard from the president there? >> yeah, you know, i just don't understand. it sounds like he's still sticking with hydroxychloroquine and azythromycin. there was work showing hydroxychloroquine worked against influenza in the test tube and unfortunately, it didn't pan out to work as a drug that actually worked in patients. so we already knew that was a bit of a red flag for hydroxychloroquine. the studies were always small. we were reserving judgment to see maybe it should be left out of larger clinical trial and eventually it was, shown not to be effective and dangerous in high doses. so i don't understand why, there seems to always be this magical thinking in the white house that we're going to, some miracle cure was going to solve the problem for the united states, and that's not how it works. even with regards to the vaccine. there's this magical thinking, again, that it's going to be like the polio vaccine we're going to bring all the press into the auditorium at the university of michigan and pull back the cu

let's jump right in and bring in dr peter hotez a vaccine ologists at the baylor college of medicine in houston dr hotez stock markets are up sharply on the news that a 1st clinical trial for the vaccine has been successful but how optimistic should we be at this stage in the testing. well it's still pretty early on in the testing there we only are only seeing information about 8 individuals and remember this is through a press release from the company there's that's not even published data so so we don't actually have any doubt to look at all we have is the opinion of the company so it's not a lot to go on what they're saying is that the 8 individuals handled the vaccine pretty well there were no immediate serious reactions one individual had some severe redness at the side of injection and some of the ones with the really highest dose may have had them or more so what we call a systemic problems of. a sudden and and and malays and that sort of thing but overall they handled it pretty well so that's good news and they also report that they developed antibodies which we would expect

peter hotez is back with us.eilemann is back. >> you've been asking the harsh questions, vaccine or no vaccine, we're back. how did he arrive at that point at his own vaccine event? >> he's frankly gotten tired of this idea that states are closed and that people are having to hunker down. he's just lost his patience that he has to continue to listen to the scientists and that more testing is needed. test is a bipartisan issue. we saw earlier this week, republican senators and democratic senators say testing is what we need if we're going to reopen. the president today shifted back was, starting to compare the virus against the flu. i think the moment you played was the moment from today, the moment for the week, the president said we're back, vaccine or no vaccine, treatment or no treatment, i want our economy going back to where it was. >> you know, john, i'm coming to you because i don't want to drag peter hotez into the president's observation. he won because enough of his primal instincts tapped into enough p

peter hotez, dean at baylor college of medicine. and dr.vin gupta, pulmonologist at the university of washington medical center, and an msnbc medical contributocontributor. peter, you and i talked before i think -- this is really early on in this thing, it was in february, before we had any meaningful community contraction of this disease. let's talk about vaccines for a minute. there are lots of parts of vaccine production. some of which can actually be shortened because you can accelerate, you can bring all the researchers together. you can accelerate certain parts of it, there's the phase one, two and three clinical trials which are human trials which have to be conducted on a statistically important number of people who do not have antibodies who are likely to get the infection to see whether it works or not, and to see whether they develop any other reactions or illnesses. i don't know if we know how to speed that up to warp speed. >> congratulations, you learned vaccine 101, that's exactly right. this is what the problem is, we'll hav

peter hotez, thank you so much, we appreciate your time. a programming note for parents, the sesame street crew returns with a family town hall, "the abcs of covid-19," saturday morning at 10:00 a.m. eastern, only on cnn. >>> the latest discussions are not founding positive for a launch today. let's go straight to cnn's rachel crane, live for us at kennedy space center in florida. rachel, give us the update, what's happening right now? >> reporter: jake, i'm sad to deliver the news that today's launch has officially been scrubbed due to weather. just 16 minutes and 23 seconds before scheduled liftoff here at kennedy space center. a backup window is planned for may 30, that's saturday. and a backup to the backup, because these weather situations and launches, they're very precarious, that is scheduled for may 31. but of course today was an instantaneous launch window. unfortunately mother nature was not on our side. but now bob behnken and doug hurley, the two astronauts strapped into the crew capsule right now, they'll be taken off the rock

peter hotez is back with us along with cnn's senior medical correspondent elizabeth cohen.u. what exactly does this study say and why is it so significant? >> dana, one of the reasons why this is so significant is this is by far the largest city that's looked at hospitalized patients sort of retrospectively to see how they did when they were given these drugs. let's take a look at the numbers. 671 hospitals looked at patients in six different continents. nearly 15,000 patients who received hydroxychloroquine or chloroquine, sometimes in combination with other drugs. what they found is that the patients who got those drugs were 33 to 45% more likely to die even after they adjusted for the fact that the patients who got the drugs were sicker than the patients who didn't get the drugs to begin with. also they were between 2.4 and 5 times more likely to develop heart arrhythmias. according to every agency out there and every expert i talked to, they said, look, this means we should not be giving these drugs to hospitalized patients unless it's part of some study. the question i

peter hotez. >> my concern is if we rush too quickly and consider cutting out critical steps.may not have a full assessment of the safety of that vaccine. so, it's still going to take some time. i still think 12 to 18 months is an aggressive schedule. and i think it's going to take longer than that to do so. >> all right. joining me now, dr. peter hotez, dean at baylor college of medicine and co-director at the center for vaccine development at texas children's hospital in houston. and dr. gupta, expert at the university of washington medical center and msnbc medical contributor. thanks to both of you. peter, you and i talked before i think -- i mean, this is really early on in this thing. it was in february. before we had, probably, any meaningful community contraction of this disease. let's just talk about vaccines for a minute. there are lots of parts of vaccine production. some of which can actually be shortened because you can accelerate. you can bring all the researchers together. you can accelerate certain parts of it. but there's the phase one, two, but mostly phase th

peter hotez who is developing a vaccine himself worries that trying to speed up the process may sacrifice the public's confidence. >> i don't think we should have magical thinking that we're going to have a vaccine in the matter of weeks or months. >> reporter: there is no way to cut corners he says. a safe, effective and trusted vaccine takes time stephanie gosk, nbc news, new york >>> up next for us tonight, richard engel inside in italy now reopening. >>> tonight one of the hardest hit countries is finally starting to reopen our richard engel is in italy. >> reporter: italy is coming back and life is finally returning to the eternal city at rome's overlooking st. peters basilica, first walks, first jogs, parks had been off limits until now. this is the first time carlo and francesca have been out of their homes since italy went into a total lockdown nearly two months ago. happy you're out in the sunshine >> i'm very happy. >> reporter: it's stupendous shining e sun that's he sd. italy was hard hit by covid with ound 1,000 deaths a day. no deaths are down up to 75% on some days but ital

for more, i'm joined now from houston, texas by professor peter hotez, dean of the national school ofmedicine. thank you so much for your company. let us start off by asking you, talking about the vaccine being needed globally, how likely is it that everyone is going to have its fairshare of that everyone is going to have its fair share of the vaccine at the same time? that is a great question and it really depends on which vaccine seems to be working the best and safest and it really depends on the type of technology that is used and how easily it can be scaled up to make the necessary and what some people say 4 billion doses for 4 billion adults around and we will see about a paediatric vaccine after that. we are accelerating a protein vaccine that children's college of medicine, a vaccine that has the hepatitis b vaccine globally, the one that is made in brazil and india and indonesia and elsewhere, our hope is that we are designing to vaccine specifically for global health we are doing this jointly with an organisation that led to the development of the vaccine for african malaria

joining me live from houston texas is professor peter hotez, an expert in molecular virology and microbiologybeing with us. what do you make of the president's announcement that they are going to go" warp speed" in the effort to come up with a vaccine by the end of the year. i think it is really important to distinguish between a vaccine that may be manufactured at scale versus actually knowing you have a vaccine that actually works. and is safe. so i think a lot of the rhetoric we are hearing and a lot of the bluster about having a vaccine by the end of the year by the fall, has to do with the fact that they have agreed to ahead of time do large—scale manufacturing agreed to ahead of time do la rge—scale manufacturing of multiple vaccine candidates and the term they use is at risk, thatis the term they use is at risk, that is the term doctor anthony fauci uses, meaning that even though there is a chance some of these vaccines will be produce a large scale, they may not be safe and therefore they may not be used. but if you look at the real timelines for vaccine development, most of them will

peter hotez. we will be back in a moment.s is bloomberg. ♪ ♪ thoseare supportive of that are transparent and remain available to all companies or competitors equally, such as the payroll support schemes across europe, such as the u.k. loan schema. credit a triple be rating. we are opposed to come on top of that, the illegal state aid that air france will receive, the 10 billion, air italia, an airline that has been bankrupt for a number of years will now receive $3 billion without any corresponding -- corresponding supports to the other airlines in that market. is ane are calling for end to those illegal discriminatory, and confining the industry to payroll support and government loans made available to all airlines operating in those economies. >> are you going to be looking to other governments for support, to some of the payroll support schemes and other countries such as spain? the payrolly for support scheme and all of those countries and we are very grateful for that support. we are asking the question, we can survive f

peter hote z, co-director of the texas children's hospital. dr. hotez, thanks for joining us.fizer and biontech have begun testing their vaccine in the u.s., they say they have the potential to supply millions of doses in 2020 if their vaccine shows success in trials. what do you make of that timeline, is it possible? >> there's going to be quite a number of vaccines moving through the clinical pipeline. i'm hoping ours might be one of them as well. they all work with pretty much the same principle. they interfere with the spike protein binding with the receptor. it's a matter of what arm it will stimulate. you've heard about rna vaccines, there are dna vaccines, a adenovirus vaccines. you need to take the appropriate amount of time to show that the vaccines are both safe and that they actually work. that's the hard part. the principle of making the vaccine is less complicated than the fact that you've got to collect all of the data that you need to prove to the reporters and yourselves that the vaccines actually work and are safe. it's hard to see how we're going to do that b

peter hotez says we get used to hearing from our top scientists more and more, maybe even looking more to them than our elected leaders. for decades scientists have been largely invisible, but going forward they may become some of our most popular public voices. brian todd, cnn, washington. >> love our scientists. >>> this is the time of year when the spanish island of ibiza would be gearing up for millions of tourists around the world. the coronavirus has brought it to a screeching halt. cnn's scott mcclain is looking at how the island's top nightclubs are adjusting. >>> if ibiza is known for one thing, it's this. the pulsing music, near constant sunshine and beautiful beaches attract people by the boat load. this year all of the biggest venues were promoting some of the biggest names. 2020 was building up to be a banner year, then covid-19 arrived. >> looks like the morning after a pretty wild night out. >> looks hungover. >> reporter: roberta delope is a manager of awe club. >> the season is here. the summer is here. there are no flights. there are no boats. there are no -- there's

peter hotez is the dean of school of tropical medicine at baylor university and acclaimed vaccine researcheris is the same drug the president claimed he was taking for preventative measures for two weeks which he wrapped up last week but scientists from across the globe are saying that it's too dangerous to even continue in clinical trials with. how significant is that? >> yeah, a lot of this came out of a publication last week in the lancet group led by a cardiologi cardiologist with 96 patie,000 patients, in a third of those were either randomized either hydroxychloroquine, chloroquine, or hydroxychloroquine with uae zit row me or hydroxychloroquine with uae zit row z az azithromycin and then a serious arrhythmia, that was really concerning. the w.h.o. had to act part of their solidarity study looking at three or four different medications and it's clear they have to pause this one now, it's not ethical to continue and probably going to shut down pretty soon. >> unethical to continue, that encapsulates what's going on here. doctor, we're learning that oxford university's trial has a 50% ch

peter hotez, thank you for all you do. we'll talk again, i know we will. >>> top pediatricians in new york warning of, and this is their word, alarming new information about children with coronavirus and one of them will join me, one of those doctors. >>> plus, many airline passengers required to wear masks today. new signs that international travel may not return this year at all. >>> and the president attacks his predecessors in the middle of this pandemic including former president george w. bush who made this inspiring video calling for unity, over the weekend. talking about this on this monday afternoon. this is cnn. i'm brooke baldwin. hey allergy muddlers... achoo! ...do your sneezes turn heads? try zyrtec... ...it starts working hard at hour one... and works twice as hard when you take it again the next day. zyrtec muddle no more. it only takes a second for an everyday item to become dangerous. tide pods child-guard pack helps keep your laundry pacs in a safe place and your child safer. align, press and unzip. tide

i spoke to one infectious disease expert, peter hotez, on our network often, it's time for calling an audible on the tests. he said that's when the quarterback says, wait a second, we have to change everything. i learned something, and what he's saying, may be time for the white house to consider using a different test. >> you're cracking me up with that, elizabeth. do you think they'll change tactics at the white house? clearly, they should. >> i think right now, this test -- >> i'm sorry, gloria, go ahead. >> go ahead, elizabeth. >> i think right now, the white house is kind of invested in the abbott test and the president said that he feels safe because everybody who comes into contact with him is tested. then that's a problem for them. so i'm not the white house physician. i have no idea, elizabeth, i think you may have some thoughts about what they ought to do here, but if this is whatare use to protect the president and the vice president, i bet they're thinking twice about it now. >> elizabeth, gloria, thank you so much. i've missed you both, by the way. so it's great to see yo

peter hotez says we get used to hear from top scientists more and more, maybe even looking to them more than our elected leaders. he says for decades scientists have been largely invisible but now in going forward they may very well become some of our most popular public voices. brian todd, cnn, washington. >> joining us now the former acting director of the cdc, dr. richard besser and physician and public health specialist dr. matthew. dr. besser, do you agree this pandemic might make handshakes a thing of the past or that wearing masks will become part of our culture as it is in asia? are these some of these social changes here to stay? >> well, you know, culture changes is hard. it's a really hard thing to effect. the recommendation on masks, you know, the cdc put out guidance or tried to put out guidance looking at what steps should be adopted in workplaces, in schools and other settings and wearing masks is one of the things that they're recommending going forward. the caution i give, though, is that the protective value of masks is very small and so you don't want people to think

peter hotez says another part of the new normal may very well be that we get used to hearing from our top scientists more and more. maybe even looking to them more than our elected leaders. he says for decades, scientists have been invisible, but now and going forward, they're likely to become some of our most popular public voices on many, many issues, wolf. >> brian todd, very good report, thank you very much. the new normal, as they say. >>> coming up, thanks to cnn global resources, we're about to get an update on some of the top coronavirus stories around the world, including china's latest very angry response to the scathing criticism it's getting from the trump administration. we'll be right back. for nearly 100 years, we've worked to provide you with the financial strength, stability, and online tools you need. and now it's no different. because helping you through this crisis is what we're made for. what did verizon build their network for? people. and when people are depending on you to make an average of over 600 million calls and send nearly 8 billion texts every day... yo

peter hotez is a professor and dean of tropical medicine at the baylor college of medicine.hank you so much for joining us, doctor. i know you've seen the white house giving us a real-time example of how quickly and widely covid-19 can spread in the workplace, especially when you're not, i guess, using the proper measures that people would expect to be used in the workplace. what are you thinking as you watch this all go down? >> as i watch, i'm thinking, you know, if they are having this many issues in the white house, imagine routine places of work if such a thing exists? how are we doing this in law offices or target or walmart or other places of employment? this is going to be really hard to have a system in place where we can do that testing on a regular basis, then to have all of the contact tracers that we need to track down the cases. some estimates are saying for every sim positive case you may need to identify 15 contacts in order to adequately quarantine and isolate everybody. this is really tough. and we are starting to see some guidelines -- detailed guidelines.

peter hotez.iate you joining us this hour. >>> with reopening under way in some form or faushion in all 50 states, we look at states that opened first, whether they're seeing new outbreaks, spikes of the coronavirus as a result. plus, secretary of state mike pompeo facing new questions today after reporting by this very network on his use of state department resources, ie packs pair dollars to hold high-end dinners with a very high-end crowd. the way it works best for you. even the big stuff. you get a delivery experience you can always count on. you get your perfect find at a price to match on your schedule. you get free two day shipping on things that make your home feel like you! wayfair. way more than furniture. ibut that doesn't mean ayou're in this alone. we're automatically refunding our customers a portion of their personal auto premiums. we're also offering flexible payment options for those who've been financially affected by the crisis. we look forward to returning to something that fee

peter hotez with our vaccine reality check of the day which is almost a daily check-in with you.nks for sharing your expertise. >> always happy to be here. thank you, chuck. >>> up next, the coronavirus economic relief fight. we'll check in with a key democratic senator back working on the hill after this. i just love hitting the open road and telling people that liberty mutual customizes your insurance, so you only pay for what you need! [squawks] only pay for what you need. ♪ liberty. liberty. liberty. liberty. ♪ this virus is testing all of us. and it's testing the people on the front lines of this fight most of all. so abbott is getting new tests into their hands, delivering the critical results they need. and until this fight is over, we...will...never...quit. because they never quit. >>> welcome back. the u.s. senate is all in session and we're starting to hear at least chatter about what phase four of the relief will look like so with me now is senator dick durbin democratic minority leader in the senate and also the senior senator from illinois. so senator durbin, let's s

this makes an incredibly a tough story to cover in some ways and i am curious of what peter hotez thinks because he works on these vaccines. this does not fit o to any timeline that we have heard before with regards to vaccines. you are talking about many years and not many months with something like this. you are hearing from impressive individuals who have a long history of vaccine developments. moncef slaoui is responsible for making ten vaccines. the timeline from development to all the way to fda approval, the idea we are talking about the end of the year and kaitlan collins asked this question, by the end of the year, a fully approved vaccine, not just one has an emergency use authorization for healthcare workers, that's the fastest t e timeline we have heard. if you watched the group that t stage, you saw everybody clapping. that's something everybody wants and including dr. fauci. our job is ask questions and having skepticism about it and it has never been done. some of these platforms have never been done before. the type of early data that i am pretty sure dr. slaoui was talki

peter hotez also working on a vaccine at the university of washington told "the washington post" it woulde obviously very important to understand the level of antibodies in the patients because he was pointing to emerging evidence where people don't have a lot of antibodies, if they don't have enough they may in fact, you know, not be able to neutralize the virus, right? like the level of antibodies that you get is really important. do you have any sense of levels? >> i have no sense of levels. i'm not involved in looking at those but i can tell you even getting some antibodies in there while the vaccine may not be a neutralizing vaccine producing a neutralizing vaccine against a respiratory virus is going to be hard. even if you get some neutralizing antibodies that prevent vaccines will still be an effective vaccine. a vaccine that may not p present -- >> that is very useful. and i want to go now to a volunteer in the moderna coronavirus vaccine trial and also a medical student at emery. you've now gotten two doses of the vaccine, so have you been tested for antibodies yet? >> thanks fo

peter hotez. appreciate your context and very important insight. all of you try to learn lessons from each other and try to get us further along the track, if you will, in that race. thank you very much. >>> former director of the cdc is pushing for a covid-19 alert system that would grade the current risk level posed by the virus throughout the united states at any given time. take a peek here. looks a lot like the days after 9/11, similarly to how we measured the terror threat. in this case, green would urge americans to take everyday precautions, whereas red, the highest level, would recommend limiting all contact. joining us now, a former cdc official as well as director of resolve to save lives, the group behind this proposed alert system. walk us through -- i have two questions, actually. number one, why do you believe this is necessary? and number two, do you wish it was coming from the government, not from outside folks with government experience who seem to be nudging the government to do more in terms of giving people clarity? >> yeah, i

peter hotez. he's the co-director of the center for vaccine development at texas children's hospital and also worked on the vaccine for sars. dr. hotez, i don't want to present you as somebody who is an alarmist about how much -- but you do seem to be concerned that we may be presenting false hope, i guess. what is your concern about all this public talk about a fast vaccine? >> here's where we're at. i'm actually pretty confident we will eventually have a covid-19 vaccine. the theory behind it is not very complicated. you induce an immune response against the spike protein that binds with the host receptor. if you've ever seen a picture of the covid-19 picture or cartoon, you recognize the doughnut stuffed with rna and all around it are these spikes that bind to the receptor. if you make an immune response to the spike proteins you can most likely block the infection. and there's at least a dozen, we're hearing 14, probably going to be at least 20 vaccines that go into clinical trials in the unit

started to die down with regard to those other infections, i think the vaccine plans that guys like peter hotezof just went away. >> how similar are those diseases to covid? >> coronavirus is the same thing that caused sars and mers, a type of coronavirus. so, that part is similar. and some of the techniques to use sort of a genetic vaccine, some of that knowledge was gained back starting with sars back in 2003. able to build on it but each vaccine is going to be different. each pathogen is going to be different. >> dr. miller is connecticut sent in this video. let's take a look. >> hi, my name is alex. i'm 16 years old old and i tested positive for covid-19. since then i've had small painful bumps on my tongue. i was wondering if you know of any other cases with this symptom or remedies with this symptom. also, i haven't lost my sense of taste. thank you. >> dr. wynn? >> well, as far as i know there is no association that we know of between the bumps on the tongue and covid-19 although alex brings up a good point about the loss of smell and taste that even though covid-19 is a respiratory viru